US2011287489A1PendingUtilityA1
Recombinational cloning using engineered recombination sites
Est. expiryJun 7, 2015(expired)· nominal 20-yr term from priority
C12N 15/66C12N 9/00C12P 19/34C12N 15/64C12N 15/10
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
Claims
exact text as granted — not AI-modified1 . A method for synthesizing a double stranded nucleic acid molecule comprising:
(a) mixing one or more nucleic acid templates with a polypeptide having polymerase activity and one or more primers comprising at least a first recombination site or portions thereof; (b) incubating said mixture under conditions sufficient to synthesize a first nucleic acid molecule which is complementary to all or a portion of said one or more templates and which comprises at least said first recombination site or portions thereof; and (c) incubating said first nucleic acid molecule in the presence of one or more primers comprising at least a second recombination site or portions thereof under conditions sufficient to synthesize a second nucleic acid molecule complementary to all or a portion of said first nucleic acid molecule, thereby producing a double stranded nucleic acid molecule comprising at least said first and second recombination sites or portions thereof, wherein at least one of said first and second recombination sites comprises one or more mutations that remove one or more stop codons from said recombination sites.
2 . A method for synthesizing a double stranded nucleic acid molecule comprising:
(a) mixing one or more nucleic acid templates with a polypeptide having polymerase activity and one or more primers comprising at least a first recombination site or portions thereof; (b) incubating said mixture under conditions sufficient to synthesize a first nucleic acid molecule which is complementary to all or a portion of said one or more templates and which comprises at least said first recombination site or portions thereof; and (c) incubating said first nucleic acid molecule in the presence of one or more primers comprising at least a second recombination site or portions thereof under conditions sufficient to synthesize a second nucleic acid molecule complementary to all or a portion of said first nucleic acid molecule, thereby producing a double stranded nucleic acid molecule comprising at least said first and second recombination sites or portions thereof, wherein at least one of said first and second recombination sites comprises one or more mutations that avoids hairpin formation in said recombination sites.
3 . A method for synthesizing a double stranded nucleic acid molecule comprising:
(a) mixing one or more nucleic acid templates with a polypeptide having polymerase activity and one or more primers comprising at least a first recombination site or portions thereof; (b) incubating said mixture under conditions sufficient to synthesize a first nucleic acid molecule which is complementary to all or a portion of said one or more templates and which comprises at least said first recombination site or portions thereof; and (c) incubating said first nucleic acid molecule in the presence of one or more primers comprising at least a second recombination site or portions thereof under conditions sufficient to synthesize a second nucleic acid molecule complementary to all or a portion of said first nucleic acid molecule, thereby producing a double stranded nucleic acid molecule comprising at least said first and second recombination sites or portions thereof, wherein at least one of said first and second recombination sites comprises at least one nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1-16 or a DNA sequence complementary thereto.
4 . The method of claim 1 , wherein said recombination sites or portions thereof are located at or near one terminus of said double stranded nucleic acid molecule.
5 . The method of claim 2 , wherein said recombination sites or portions thereof are located at or near one terminus of said double stranded nucleic acid molecule.
6 . The method of claim 3 , wherein said recombination sites or portions thereof are located at or near one terminus of said double stranded nucleic acid molecule.
7 . The method of claim 1 , wherein said first or second recombination sites are selected from the group consisting of attB sites, attP sites, attL sites, attR sites, lox sites, and portions thereof.
8 . The method of claim 2 , wherein said first or second recombination sites are selected from the group consisting of attB sites, attP sites, attL sites, attR sites, lox sites, and portions thereof.
9 . The method of claim 3 , wherein said first or second recombination sites are selected from the group consisting of attB sites, attP sites, attL sites, attR sites, lox sites, and portions thereof.
10 . The method of claim 1 , further comprising amplifying said first and second nucleic acid molecules.
11 . The method of claim 2 , further comprising amplifying said first and second nucleic acid molecules.
12 . The method of claim 3 , further comprising amplifying said first and second nucleic acid molecules.
13 . The method of claim 1 , wherein said recombination sites or portions thereof are located at or near one or both termini of said double stranded nucleic acid molecule.
14 . The method of claim 2 , wherein said recombination sites or portions thereof are located at or near one or both termini of said double stranded nucleic acid molecule.
15 . The method of claim 3 , wherein said recombination sites or portions thereof are located at or near one or both termini of said double stranded nucleic acid molecule.
16 . The method of claim 1 , wherein said first and second recombination sites do not recombine with each other.
17 . The method of claim 2 , wherein said first and second recombination sites do not recombine with each other.
18 . The method of claim 3 , wherein said first and second recombination sites do not recombine with each other.
19 . A method for synthesizing a double stranded nucleic acid molecule comprising:
(a) mixing one or more nucleic acid templates with a polypeptide having polymerase activity and one or more primers comprising at least a first recombination site or portions thereof; (b) incubating said mixture under conditions sufficient to synthesize a first nucleic acid molecule which is complementary to all or a portion of said one or more templates and which comprises at least said first recombination site or portions thereof; and (c) incubating said first nucleic acid molecule in the presence of one or more primers comprising at least a second recombination site or portions thereof under conditions sufficient to synthesize a second nucleic acid molecule complementary to all or a portion of said first nucleic acid molecule, thereby producing a double stranded nucleic acid molecule comprising at least said first and second recombination sites or portions thereof, wherein at least one of said first and second recombination sites comprises at least one nucleotide sequence that has at least 80-99% homology to a nucleotide sequence selected from the group of sequences consisting of SEQ ID NOs: 1-16, and a corresponding or complementary DNA or RNA sequence.
20 . The method of claim 19 , wherein said recombination sites or portions thereof are located at or near one terminus of said double stranded nucleic acid molecule.
21 . The method of claim 19 , further comprising amplifying said first and second nucleic acid molecules.
22 . The method of claim 19 , wherein said recombination sites or portions thereof are located at or near one or both termini of said double stranded nucleic acid molecule.
23 . The method of claim 19 , wherein said first and second recombination sites do not recombine with each other.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.